A Canadian company will begin exporting medicinal cannabis to Auckland's Middlemore Hospital from later this month.
Tilray has been granted approvals to export oils containing THC and cannabidoil to New Zealand.
It comes days after Associate Health Minister Peter Dunne, who had been responsible for approving almost all medicinal cannabis prescriptions, downgraded requirements.
Patients now only need authorisation from the Ministry of Health for prescriptions for medicinal cannabis products.
Tilray is expected to be an alternative to Sativex, a cannabis-based mouth spray used to help multiple sclerosis patients with pain, which costs $1200 a month.
"We are proud to be able to offer patients in need access to high-quality, pharmaceutical-grade medical cannabis products," Tilray president Brendan Kennedy said in the company announcement on Wednesday.